Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00786708 · ClinicalTrials.gov registry record
Sensitivity and Specificity of NGAL in an Emergency Room Population
A clinical trial of Renal Insufficiency, Chronic and Hydronephrosis, sponsored by Columbia University.
- Completed
- Registry status
- 2,304
- Enrollment target
- 3
- Study locations
NCT00786708: Completed study of Renal Insufficiency, Chronic and Hydronephrosis, sponsored by Columbia University.
NCT00786708 is a study of Renal Insufficiency, Chronic and Hydronephrosis that has completed, run by Columbia University. The registered enrollment target is 2,304 participants, above the 485-participant average among 14 other Renal Insufficiency, Chronic trials with a reported enrollment target (375% higher). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00786708, a study of Renal Insufficiency, Chronic and Hydronephrosis, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 2,304 participants
- Enrollment target
- 3
- Study locations
Study Summary
Hypothesis: In patients that present to an urban emergency room, a single urine neutrophil gelatinase-associated lipocalin (NGAL) measurement can classify their kidney disease as stable chronic kidney disease, acute tubular necrosis, urinary outlet obstruction or pre-renal azotemia.
Conditions Studied
Study Locations (3)
New York
- Columbia University Medical Center - New York
- Staten Island University Hospital - Staten Island
Other
- Charite University Medical Center - Berlin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,304 participants |
| Start Date | 2006-12 |
| Est. Completion | 2013-07 |
What the finished NCT00786708 record still lists
NCT00786708 is an observational study that tracks outcomes without assigning an intervention. Its 2,304 participants enrollment target places it among the larger protocols in the corpus, above the 485-participant average among 14 other Renal Insufficiency, Chronic trials with a reported enrollment target (375% higher).
The record links to 4 conditions, with Renal Insufficiency, Chronic appearing as the primary indexed condition, and to 0 interventions.
NCT00786708 reports a single indexed study location in New York, Other.
Frequently Asked Questions
What is clinical trial NCT00786708 about?
NCT00786708 is a clinical study titled "Sensitivity and Specificity of NGAL in an Emergency Room Population". Hypothesis: In patients that present to an urban emergency room, a single urine neutrophil gelatinase-associated lipocalin (NGAL) measurement can classify their kidney disease as stable chronic kidney disease, acute tubular necrosis, urinary outlet obstruction or pre-renal azotemia.
What is the current status of trial NCT00786708?
This trial is currently completed. The enrollment target is 2,304 participants. The study started on 2006-12. Estimated completion is 2013-07.
What conditions does trial NCT00786708 study?
This clinical trial studies the following conditions: Renal Insufficiency, Chronic, Hydronephrosis, Renal Failure, Acute, Azotemia.
Who is sponsoring clinical trial NCT00786708?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00786708 being conducted?
This trial has 3 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Renal Insufficiency, Chronic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00786708's enrollment target sits among peer trials
2,304 2nd of 14 the highest of 14 other Renal Insufficiency, Chronic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Renal Insufficiency, Chronic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neurovascular Transduction During Exercise in Chronic Kidney Disease
RECRUITING · Phase 2
-
Transformative Research in Diabetic Nephropathy 2.0
RECRUITING
-
A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function
RECRUITING · Phase 1
-
Penn Produce Prescription and Chronic Kidney Disease Study
ACTIVE NOT RECRUITING · NA
-
Acute Kidney Injury Genomics and Biomarkers in TAVR Study
ACTIVE NOT RECRUITING
-
SDCC - Prospective Cohort Study of Chronic Renal Insufficiency
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04124120 · 2,300 participants · NA
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
- NCT05237258 · 2,300 participants · NA
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
- NCT05732623 · 2,300 participants
Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
- NCT05759988 · 2,300 participants · NA
Cervical Ripening as an Outpatient Method Using the Foley (COMFORT)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia